Recombinant TIGIT anticorps

N° du produit ABIN7826145

Cet anticorps anti-TIGIT est un anticorps Lapin Monoclonal détectant TIGIT dans IHC. Adapté pour Humain.

Aperçu rapide pour Recombinant TIGIT anticorps (ABIN7826145)

Antigène: TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp TIGIT est non-conjugé

Application: Immunohistochemistry (IHC)

Clone: HMV322

Détail du produit anti-TIGIT anticorps

Fonction: TIGIT antibody (HMV322)

Immunogène: Recombinant human TIGIT fragment

Isotype: IgG

Information d'application

Indications d'application: IHC 1:100-1:200

Commentaires:

Positive Control: Tonsil: A moderate to strong TIGIT staining should be seen in a subset of germinal centre cells (CD4+ follicular T helper cells located in the germinal centre periphery orientated towards the tonsil surface epithelium). Subsets of other lymphocytes should also be positive but less intense.

Product Description/Background: TIGIT antibody validated for immunohistochemistry on 76 different Normal Tissues

Negative Control: Tonsil: TIGIT staining should be absent in all epithelial cells and in most lymphocytes.

Protocole: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37 °C for 60 minutes.

Restrictions: For Research Use only

Stockage

Format: Liquid

Stock: 4 °C,-20 °C,-80 °C

Stockage commentaire: Antibody with azide - store at 2 to 8 C. Antibody without azide - store at -20 to -80 C. Antibody is stable for 24 months. Non- hazardous. No MSD required.

Date de péremption: 24 months

Détails sur TIGIT

Antigène: TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))

Autre désignation: TIGIT

Sujet: Gene Alias: T cell immunoreceptor with Ig and ITIM domains , VSIG9 , VSTM3 , WUCAM

UniProt: Q495A1

Pathways: Cancer Immune Checkpoints